• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) QUADRA ASSURA DDQP+; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) QUADRA ASSURA DDQP+; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD3267-40Q
Device Problems Battery Problem (2885); Inappropriate or Unexpected Reset (2959)
Patient Problem Muscle Stimulation (1412)
Event Date 02/14/2020
Event Type  Injury  
Manufacturer Narrative
The device is included in the battery performance alert advisory issued by abbott on 28 august 2017.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported that the patient experienced diaphragmatic stimulation following vibratory alerts.Backup vvi was observed (b)(6) 2020 and was addressed and resolved.The patient experienced an additional vibratory alert on (b)(6) 2020 for a battery performance alert (bpa) advisory.The device was explanted and replaced.The patient was stable.
 
Manufacturer Narrative
The reported field event of backup vvi was verified in the lab.However, the root cause of the reset could not be conclusively determined since the device was reprogrammed in the field and the event was not reproducible.Testing was performed and the device was found to be normal; telemetry, pacing, sensing, impedance, high voltage (hv) output, high voltage (hv) shock and patient notifier were tested on the bench.No anomaly was detected.The diaphragmatic stimulation could not be confirmed in the lab.The cause is most likely consistent with the lead positioning.The battery performance alert (bpa) was verified in the lab.However, further investigation showed the battery performance alert (bpa) was a false positive.Prior to the event, device code was reloaded in the field, which cleared the device¿s usage data as part of the procedure.The bpa algorithm uses device usage history data for calculations and since that data got cleared after reloading code, a false bpa was triggered.This is normal and expected behavior when the data is cleared and the device had been implanted for >7 years.Additional information: d10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUADRA ASSURA DDQP+
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
MDR Report Key9789963
MDR Text Key182109994
Report Number2017865-2020-02831
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Recall
Type of Report Initial,Followup
Report Date 05/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2014
Device Model NumberCD3267-40Q
Device Lot Number4066927
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2020
Was the Report Sent to FDA? No
Date Manufacturer Received05/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0004-2018
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
-
-